Cited by 3,047Cancer-related Molecular PathwaysDNA Repair MechanismsEffects of Radiation Exposure

The DOI matches its Crossref record; 59 of the 64 references it cites were found in a registry or an index.

A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia

Kastan, Michael B., Zhan, Qimin, El-Deiry, Wafik S., Carrier, France, Jacks, Tyler, Walsh, William V., Plunkett, Beverly S., Vogelstein, Bert, Fornace, Albert J.·1992·Cell

DOI 10.1016/0092-8674(92)90593-2

Open this paper in CoChat — free account

Abstract

Cell cycle checkpoints can enhance cell survival and limit mutagenic events following DNA damage. Primary murine fibroblasts became deficient in a G1 checkpoint activated by ionizing radiation (IR) when both wild-type p53 alleles were disrupted. In addition, cells from patients with the radiosensitive, cancer-prone disease ataxia-telangiectasia (AT) lacked the IR-induced increase in p53 protein levels seen in normal cells. Finally, IR induction of the human GADD45 gene, an induction that is also defective in AT cells, was dependent on wild-type p53 function. Wild-type but not mutant p53 bound strongly to a conserved element in the GADD45 gene, and a p53-containing nuclear factor, which bound this element, was detected in extracts from irradiated cells. Thus, we identified three participants (AT gene(s), p53, and GADD45) in a signal transduction pathway that controls cell cycle arrest following DNA damage; abnormalities in this pathway probably contribute to tumor development.

Integrity signals

Registry

Crossref · 10.1016/0092-8674(92)90593-2

Cites

59 of 59 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction
Chomczynski, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1006/abio.1987.9999 · Cited by 65,515
Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei
Dignam, J. D., Lebovitz, R. M., & Roeder, R. G. (1983) · Nucleic Acids Research · doi:10.1093/nar/11.5.1475 · Cited by 11,262
p53 Mutations in Human Cancers
Hollstein, M., Sidransky, D., Vogelstein, B., & Harris, C. C. (1991) · Science · doi:10.1126/science.1905840 · Cited by 8,018
Self-citation
Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Butel, J. S., & Bradley, A. (1992) · Nature · doi:10.1038/356215a0 · Cited by 4,649
The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53
Scheffner, M., Werness, B. A., Huibregtse, J. M., Levine, A. J., & Howley, P. M. (1990) · Cell · doi:10.1016/0092-8674(90)90409-8 · Cited by 3,995
The Causes of Cancer: Quantitative Estimates of Avoidable Risks of Cancer in the United States Today
Doll, R., & Peto, R. (1981) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/66.6.1192 · Cited by 3,927 · cited 1×
“Discussion Exposure to DNA-damaging agents probably contributes to the development of a significant percentage of human cancers (Doll and Peto, 1981).”
Background
Germ Line p53 Mutations in a Familial Syndrome of Breast Cancer, Sarcomas, and Other Neoplasms
Malkin, D., Li, F. P., Strong, L. C., Fraumeni, J. F., Nelson, C. E., Kim, D. H., Kassel, J., Gryka, M. A., Bischoff, F. Z., Tainsky, M. A., et al. (1990) · Science · doi:10.1126/science.1978757 · Cited by 3,765
Participation of p53 protein in the cellular response to DNA damage.
Kastan, M. B., Onyekwere, O. C., Sidransky, D., Vogelstein, B., & Craig, R. W. (1991) · PubMed · Cited by 3,761
Self-citation
The Causes of Cancer: Quantitative Estimates of Avoidable Risks of Cancer in the United States Today
Peto, R. (1983) · Springer eBooks · doi:10.1007/978-1-4757-1117-2_30 · Cited by 3,504
The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation
Momand, J., Zambetti, G. P., Olson, D. C., George, D., & Levine, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90644-r · Cited by 3,113

Show all 64 references

Sorted by citations

Items 601–700 of 1,007

Genomic instability, centrosome amplification, cell cycle checkpoints and Gadd45a
Hollander, M. C., & Fornace, A. J. (2002) · Oncogene · doi:10.1038/sj.onc.1205774 · Cited by 144
Self-citation
Transcriptional regulation of basic fibroblast growth factor gene by p53 in human glioblastoma and hepatocellular carcinoma cells.
Ueba, T., Nosaka, T., Takahashi, J. A., Shibata, F., Florkiewicz, R. Z., Vogelstein, B., Oda, Y., Kikuchi, H., & Hatanaka, M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.19.9009 · Cited by 142
Self-citation
The cellular decision between apoptosis and autophagy
Fan, Y., & Zong, W. (2012) · 癌症：英文版 · doi:10.5732/cjc.012.10106 · Cited by 142
Chromosome breakage syndromes and cancer
Duker, N. J. (2002) · American Journal of Medical Genetics · doi:10.1002/ajmg.10688 · Cited by 146
Inhibition of p53 Transcriptional Activity by the S100B Calcium-binding Protein
Lin, J., Blake, M., Tang, C., Zimmer, D. B., Rustandi, R. R., Weber, D. J., & Carrier, F. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104379200 · Cited by 141
Self-citation
The Human G2 Checkpoint Control Protein hRAD9 Is a Nuclear Phosphoprotein That Forms Complexes with hRAD1 and hHUS1
St.Onge, R. P., Udell, C. M., Casselman, R., & Davey, S. K. (1999) · Molecular Biology of the Cell · doi:10.1091/mbc.10.6.1985 · Cited by 141
p53 functional impairment and high p21waf1/cip1 expression in human T- cell lymphotropic/leukemia virus type I-transformed T cells
Cereseto, A., Diella, F., Mulloy, J. C., Cara, A., Michieli, P., Grassmann, R., Franchini, G., & Klotman, M. (1996) · Blood · doi:10.1182/blood.v88.5.1551.1551 · Cited by 141
Manipulation of Base Excision Repair to Sensitize Ovarian Cancer Cells to Alkylating Agent Temozolomide
Fishel, M. L., He, Y., Smith, M. L., & Kelley, M. R. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1920 · Cited by 140
The roles of telomeres and telomerase in cell life span
Counter, C. M. (1996) · Mutation Research/Reviews in Genetic Toxicology · doi:10.1016/s0165-1110(96)90006-8 · Cited by 139
Ataxia telangiectasia
Crawford, T. O. (1998) · Seminars in Pediatric Neurology · doi:10.1016/s1071-9091(98)80007-7 · Cited by 140
The pro-longevity gene FoxO3 is a direct target of the p53 tumor suppressor
Renault, V. M., Thekkat, P. U., Hoang, K., White, J. L., Brady, C. A., Brož, D. K., Venturelli, O. S., Johnson, T. M., Oskoui, P. R., Xuan, Z., et al. (2011) · Oncogene · doi:10.1038/onc.2011.35 · Cited by 139
Chk2 is dispensable for p53-mediated G 1 arrest but is required for a latent p53-mediated apoptotic response
Jack, M. T., Woo, R. A., Hirao, A., Cheung, A., Mak, T. W., & Lee, P. W. K. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.152053599 · Cited by 140
Death and more: DNA damage response pathways in the nematode C. elegans
Stergiou, L., & Hengartner, M. O. (2003) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401340 · Cited by 140
Flavonoid Antioxidant Silymarin and Skin Cancer
Singh, R. P., & Agarwal, R. (2002) · Antioxidants and Redox Signaling · doi:10.1089/15230860260220166 · Cited by 138
Molecular mechanisms of ionizing radiation‐induced apoptosis
Watters, D. J. (1999) · Immunology and Cell Biology · doi:10.1046/j.1440-1711.1999.00824.x · Cited by 138
Double-Stranded-RNA-Activated Protein Kinase PKR Enhances Transcriptional Activation by Tumor Suppressor p53
Cuddihy, A. R., Li, S., Tam, N. W. N., Wong, A. H., Taya, Y., Abraham, N., Bell, J. C., & Koromilas, A. E. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.4.2475 · Cited by 137
Loss of Expression ofGADD45γ, a Growth Inhibitory Gene, in Human Pituitary Adenomas: Implications for Tumorigenesis
Zhang, X., Sun, H., Danila, D. C., Johnson, S. R., Zhou, Y., Swearingen, B., & Klibanski, A. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.3.8315 · Cited by 137
An Inhibitor of Nuclear Export Activates the p53 Response and Induces the Localization of HDM2 and p53 to U1A-Positive Nuclear Bodies Associated with the PODs
Laín, S., Midgley, C., Sparks, A., Lane, E. B., & Lane, D. P. (1999) · Experimental Cell Research · doi:10.1006/excr.1999.4433 · Cited by 136
Stabilization of p53 Is a Novel Mechanism for Proapoptotic Function of NF-κB
Fujioka, S., Schmidt, C., Sclabas, G. M., Li, Z., Pelicano, H., Peng, B., Yao, A., Niu, J., Zhang, W., Evans, D. B., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313435200 · Cited by 139
Defect in Multiple Cell Cycle Checkpoints in Ataxia-Telangiectasia Postirradiation
Beamish, H., Williams, R. T., Chen, P., & Lavin, M. F. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.34.20486 · Cited by 137
Early Growth Response 1 Acts as a Tumor Suppressor In vivo and In vitro via Regulation of p53
Krones‐Herzig, A., Mittal, S., Yule, K., Liang, H., English, C. N., Urcis, R., Soni, T., Adamson, E. D., & Mercola, D. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3742 · Cited by 136
Review: ATM: the protein encoded by the gene mutated in the radiosensitive syndrome ataxia-telangiectasia
Lavin, M. F. (1999) · International Journal of Radiation Biology · doi:10.1080/095530099139359 · Cited by 137
Insights into cancer therapeutic design based on p53 and TRAIL receptor signaling
El‐Deiry, W. S. (2001) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400943 · Cited by 136
Self-citation
UV-radiation induces dose-dependent regulation of p53 response and modulates p53-HDM2 interaction in human fibroblasts
Latonen, L., Taya, Y., & Laiho, M. (2001) · Oncogene · doi:10.1038/sj.onc.1204883 · Cited by 134
The ZNF217 gene amplified in breast cancers promotes immortalization of human mammary epithelial cells.
Nonet, G. H., Stampfer, M. R., Chin, K., Gray, J. W., Collins, C. C., & Yaswen, P. (2001) · PubMed · Cited by 135
Expression of human p53 requires synergistic activation of transcription from the p53 promoter by AP-1, NF-κB and Myc/Max
Kirch, H.-C., Flaswinkel, S., Rumpf, H., Brockmann, D., & Esche, H. (1999) · Oncogene · doi:10.1038/sj.onc.1202626 · Cited by 137
p53 is a potential mediator of pregnancy and hormone-induced resistance to mammary carcinogenesis
Sivaraman, L., Conneely, O. M., Medina, D., & O’Malley, B. W. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.221459098 · Cited by 135
Evidence that the death receptor DR4 is a DNA damage‐inducible, p53‐regulated gene
Guan, B., Yue, P., Clayman, G. L., & Sun, S. (2001) · Journal of Cellular Physiology · doi:10.1002/jcp.1101 · Cited by 135
DNA damage induces downregulation of histone gene expression through the G1 checkpoint pathway
Su, C., Gao, G., Schneider, S. M., Helt, C. E., Weiß, C., O’Reilly, M. A., Bohmann, D., & Zhao, J. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600120 · Cited by 135
Expression of BCL-2 Oncoprotein and P53 Protein Accumulation in Bone Marrow Metastases of Androgen Independent Prostate Cancer
McDonnel, T. J., Navone, N. M., Troncoso, P., Pisters, L. L., Conti, C. J., von Eschenbach, A. C., Brisbay, S. M., & Logothetis, C. J. (1997) · The Journal of Urology · doi:10.1016/s0022-5347(01)65204-2 · Cited by 134
Suppression of growth in vitro and tumorigenicity in vivo of human carcinoma cell lines by transfectedp16INK4
Spillare, E. A., Okamoto, A., Hagiwara, K., Demetrick, D. J., Serrano, M., Beach, D., & Harris, C. C. (1996) · Molecular Carcinogenesis · doi:10.1002/(sici)1098-2744(199605)16:1 · Cited by 36
Nek family of kinases in cell cycle, checkpoint control and cancer
Moniz, L. S., Dutt, P., Haider, N., & Stambolic, V. (2011) · Cell Division · doi:10.1186/1747-1028-6-18 · Cited by 132
Biogenesis of p53 Involves Cotranslational Dimerization of Monomers and Posttranslational Dimerization of Dimers
Nicholls, C. D., McLure, K. G., Shields, M. A., & Lee, P. W. K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108815200 · Cited by 136
Alternative and aberrant messenger RNA splicing of the mdm2 oncogene in invasive breast cancer.
Lukáš, J., Gao, D. Q., Keshmeshian, M., Wen, W., Tsao-Wei, D. D., Rosenberg, S. A., & Press, M. F. (2001) · PubMed · Cited by 133
p53/p21(CIP1) cooperate in enforcing rapamycin-induced G(1) arrest and determine the cellular response to rapamycin.
Huang, S., Liu, L. N., Hosoi, H., Dilling, M. B., Shikata, T., & Houghton, P. J. (2001) · PubMed · Cited by 130
Progress towards a clinically-successful ATR inhibitor for cancer therapy
Barnieh, F. M., Loadman, P. M., & Falconer, R. A. (2021) · Current Research in Pharmacology and Drug Discovery · doi:10.1016/j.crphar.2021.100017 · Cited by 134
The potential role of DFNA5, a hearing impairment gene, in p53-mediated cellular response to DNA damage
Masuda, Y. M., Futamura, M., Kamino, H., Nakamura, Y., Kitamura, N., Ohnishi, S., Miyamoto, Y., Ichikawa, H., Ohta, T., Ohki, M., et al. (2006) · Journal of Human Genetics · doi:10.1007/s10038-006-0004-6 · Cited by 131
Transcriptional activation of the human proliferating-cell nuclear antigen promoter by p53.
Morris, G. F., Bischoff, J. R., & Mathews, M. B. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.2.895 · Cited by 131
The ataxia-telangiectasia related protein ATR mediates DNA-dependent phosphorylation of p53
Lakin, N. D., Hann, B. C., & Jackson, S. P. (1999) · Oncogene · doi:10.1038/sj.onc.1202973 · Cited by 135
p53 oligomerization and DNA looping are linked with transcriptional activation.
Stenger, J. E., Tegtmeyer, P., Mayr, G. A., Reed, M. J., Wang, Y., Wang, P., Hough, P. V. C., & Mastrangelo, I. A. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06947.x · Cited by 130
Gadd45a and Gadd45b Protect Hematopoietic Cells from UV-induced Apoptosis via Distinct Signaling Pathways, including p38 Activation and JNK Inhibition
Gupta, M., Gupta, S. K., Hoffman‐Liebermann, B., & Liebermann, D. A. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600950200 · Cited by 131
Mammalian DNA damage-inducible genes associated with growth arrest and apoptosis
Smith, M. L., & Fornace, A. J. (1996) · Mutation Research/Reviews in Genetic Toxicology · doi:10.1016/s0165-1110(96)90043-3 · Cited by 129
Self-citation
Trp53-dependent DNA-repair is affected by the codon 72 polymorphism
Siddique, M. M., & Sabapathy, K. (2006) · Oncogene · doi:10.1038/sj.onc.1209405 · Cited by 128
Requirement of ATM in Phosphorylation of the Human p53 Protein at Serine 15 following DNA Double-Strand Breaks
Nakagawa, K., Taya, Y., Tamai, K., & Yamaizumi, M. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.4.2828 · Cited by 134
Functional Interaction of H2AX, NBS1, and p53 in ATM-Dependent DNA Damage Responses and Tumor Suppression
Kang, J., Ferguson, D. O., Song, H., Bassing, C. H., Eckersdorff, M., Alt, F. W., & Xu, Y. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.2.661-670.2005 · Cited by 133
The p53QS transactivation-deficient mutant shows stress-specific apoptotic activity and induces embryonic lethality
Johnson, T. M., Hammond, E. M., Giaccia, A. J., & Attardi, L. D. (2005) · Nature Genetics · doi:10.1038/ng1498 · Cited by 134
Specific Mismatch Recognition in Heteroduplex Intermediates by p53 Suggests a Role in Fidelity Control of Homologous Recombination
Dudenhöffer, C., Rohaly, G., Will, K., Deppert, W., & Wiesmüller, L. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.9.5332 · Cited by 129
Tumor suppressor p53 and its gain-of-function mutants in cancer
Liu, J., Zhang, C., & Feng, Z. (2013) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmt144 · Cited by 133
p53 Tumor Suppressor Gene: At the Crossroads of Molecular Carcinogenesis, Molecular Epidemiology, and Cancer Risk Assessment
Harris, C. C. (1996) · Environmental Health Perspectives · doi:10.1289/ehp.96104s3435 · Cited by 135
The Product of the ATM Gene Is a 370-kDa Nuclear Phosphoprotein
Chen, G., & Lee, E. Y.-H. P. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.52.33693 · Cited by 129
Solution structure of the Hdm2 C2H2C4 RING, a domain critical for ubiquitination of p53
Kostic, M., Matt, T., Martinez-Yamout, M. A., Dyson, H. J., & Wright, P. E. (2006) · Journal of Molecular Biology · doi:10.1016/j.jmb.2006.08.027 · Cited by 128
p53-independent induction of Gadd45 by histone deacetylase inhibitor: coordinate regulation by transcription factors Oct-1 and NF-Y
Hirose, T., Sowa, Y., Takahashi, S., Saito, S., Yasuda, C., Shindo, N., Furuichi, K., & Sakai, T. (2003) · Oncogene · doi:10.1038/sj.onc.1207091 · Cited by 128
Inhibiting S100B Restores p53 Levels in Primary Malignant Melanoma Cancer Cells
Lin, J., Yang, Q., Yan, Z., Markowitz, J., Wilder, P. T., Carrier, F., & Weber, D. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405419200 · Cited by 128
Self-citation
Modulation of p53 expression in cultured colonic adenoma cell lines by the naturally occurring lumenal factors butyrate and deoxycholate
Palmer, D. G., Paraskeva, C., & Williams, A. C. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19971127)73:5 · Cited by 26
Downregulation of the type 1 insulin-like growth factor receptor in mouse melanoma cells is associated with enhanced radiosensitivity and impaired activation of Atm kinase
Macaulay, V. M., Salisbury, A. J., Bohula, E. A., Playford, M. P., Smorodinsky, N. I., & Shiloh, Y. (2001) · Oncogene · doi:10.1038/sj.onc.1204565 · Cited by 128
Cip1 blocks the initiation of DNA replication in Xenopus extracts by inhibition of cyclin-dependent kinases
Strausfeld, U. P., Howell, M., Rempel, R. E., Maller, J. L., Hunt, T., & Blow, J. J. (1994) · Current Biology · doi:10.1016/s0960-9822(00)00196-2 · Cited by 128
Evaluation of transgenic mouse bioassays for identifying carcinogens and noncarcinogens
Tennant, R. W., Spalding, J. W., & French, J. E. (1996) · Mutation Research/Reviews in Genetic Toxicology · doi:10.1016/s0165-1110(96)90016-0 · Cited by 130
Death-defying acts: a meeting review on apoptosis.Preprint
White, E. (1993) · Genes & Development · doi:10.1101/gad.7.12a.2277 · Cited by 128
Ataxia Telangiectasia Mutated-Dependent Apoptosis after Genotoxic Stress in the Developing Nervous System Is Determined by Cellular Differentiation Status
Lee, Y., Chong, M. J., & McKinnon, P. J. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-17-06687.2001 · Cited by 132
The Ataxia telangiectasia Gene Product Is Required for Oxidative Stress-induced G1 and G2Checkpoint Function in Human Fibroblasts
Shackelford, R. E., Innes, C. L., Sieber, S. O., Heinloth, A. N., Leadon, S. A., & Paules, R. S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011303200 · Cited by 127
The carboxy terminus of NBS1 is required for induction of apoptosis by the MRE11 complex
Stracker, T. H., Morales, M., Couto, S. S., Hussein, H., & Petrini, J. H. J. (2007) · Nature · doi:10.1038/nature05740 · Cited by 126
Terminal dendritic sprouting and reactive synaptogenesis in the postnatal organ of Corti in culture
Sobkowicz, H. M., August, B. K., Slapnick, S. M., & Luthy, D. F. (1998) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19980727)397:2 · Cited by 9
Recent Advances in Radiation Oncology
Lichter, A. S., & Lawrence, T. S. (1995) · New England Journal of Medicine · doi:10.1056/nejm199502093320607 · Cited by 127
A temperature‐sensitive mutant of human p53.
Zhang, W., Guo, X. Y., Hu, G., Liu, W. B., Shay, J. W., & Deisseroth, A. B. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06543.x · Cited by 127
The dihedral symmetry of the p53 tetramerization domain mandates a conformational switch upon DNA binding.
Waterman, J. L. F., Shenk, J. L., & Halazonetis, T. D. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07027.x · Cited by 129
Defective apoptosis and B-cell lymphomas in mice with p53 point mutation at Ser 23
MacPherson, D., Kim, J., Kim, T., Rhee, B. K., van Oostrom, C. T., DiTullio, R. A., Venere, M., Halazonetis, T. D., Bronson, R., de Vries, A., et al. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600363 · Cited by 124
BRCA1 Regulates GADD45 through Its Interactions with the OCT-1 and CAAT Motifs
Fan, W., Jin, S., Tong, T., Zhao, H., Fan, F., Antinore, M. J., Rajasekaran, B., Wu, M., & Zhan, Q. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110225200 · Cited by 125
Self-citation
Osmotic Shock Induces G1 Arrest through p53 Phosphorylation at Ser33 by Activated p38MAPK without Phosphorylation at Ser15 and Ser20
Kishi, H., Nakagawa, K., Matsumoto, M., Suga, M., Ando, M., Taya, Y., & Yamaizumi, M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105134200 · Cited by 129
Activation of Caspases and p53 by Bovine Herpesvirus 1 Infection Results in Programmed Cell Death and Efficient Virus Release
Devireddy, L. R., & Jones, C. (1999) · Journal of Virology · doi:10.1128/jvi.73.5.3778-3788.1999 · Cited by 125
Myc-mediated transformation: the repression connection
Claassen, G. F., & Hann, S. (1999) · Oncogene · doi:10.1038/sj.onc.1202747 · Cited by 127
Biological determinants of radioresistance and their remediation in pancreatic cancer
Seshacharyulu, P., Baine, M. J., Souchek, J. J., Menning, M., Kaur, S., Yan, Y., Ouellette, M. M., Jain, M., Lin, C. H., & Batra, S. K. (2017) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2017.02.003 · Cited by 127
Roles of poly(ADP-ribosyl)ation and PARP in apoptosis, DNA repair, genomic stability and functions of p53 and E2F-1
Smulson, M. E., Simbulan-Rosenthal, C. M., Boulares, A. H., Yakovlev, A., Stoica, B. A., Iyer, S., Luo, R., Haddad, B. R., Wang, Z., Pang, T.-L., et al. (2000) · Advances in Enzyme Regulation · doi:10.1016/s0065-2571(99)00024-2 · Cited by 124
New Concepts on the Role of Human Papillomavirus in Cell Cycle Regulation
Syrjänen, S., & Syrjänen, K. J. (1999) · Annals of Medicine · doi:10.3109/07853899909115976 · Cited by 122
Regulation of p53-dependent apoptosis, transcriptional repression, and cell transformation by phosphorylation of the 55-kilodalton E1B protein of human adenovirus type 5
Teodoro, J. G., & Branton, P. E. (1997) · Journal of Virology · doi:10.1128/jvi.71.5.3620-3627.1997 · Cited by 124
Ataxia Telangiectasia-mutated Gene Product Inhibits DNA Damage-induced Apoptosis via Ceramide Synthase
Liao, W., Haimovitz‐Friedman, A., Persaud, R. S., McLoughlin, M., Ehleiter, D., Zhang, N., Gatei, M. H., Lavin, M. F., Kolesnick, R., & FUKS, Z. Y. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.25.17908 · Cited by 122
Spontaneous and ionizing radiation-induced chromosomal abnormalities in p53-deficient mice.
Bouffler, S. D., Kemp, C. J., Balmain, A., & Cox, R. (1995) · PubMed · Cited by 121
Tumor viruses and cancer biology: Modulating signaling pathways for therapeutic intervention
Saha, A., Kaul, R., Murakami, M., & Robertson, E. S. (2010) · Cancer Biology & Therapy · doi:10.4161/cbt.10.10.13923 · Cited by 123
MicroRNAs in colorectal carcinoma - from pathogenesis to therapy
Chi, Y., & Zhou, D. (2016) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-016-0320-4 · Cited by 126
Down-regulation of the stathmin/Op18 and FKBP25 genes following p53 induction
Ahn, J., Murphy, M. E., Kratowicz, S. A., Wang, A., Levine, A. J., & George, D. L. (1999) · Oncogene · doi:10.1038/sj.onc.1202986 · Cited by 122
Functional Domains of Wild-Type and Mutant p53 Proteins Involved in Transcriptional Regulation, Transdominant Inhibition, and Transformation Suppression
Unger, T., Mietz, J. A., Scheffner, M., Yee, C., & Howley, P. M. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.9.5186 · Cited by 127
Keeping an old friend under control: regulation of p53 stability
Kubbutat, M. H. G., & Vousden, K. H. (1998) · Molecular Medicine Today · doi:10.1016/s1357-4310(98)01260-x · Cited by 122
p53 but not bcl-2 immunostaining is predictive of poor clinical complete response to primary chemotherapy in breast cancer patients.
Bottini, A., Berruti, A., Bersiga, A., Brizzi, M. P., Brunelli, A., Gorzegno, G., DiMarco, B., Aguggini, S., Bolsi, G., Cirillo, F., et al. (2000) · PubMed · Cited by 123
Cooperative DNA binding of p53 with TFIID (TBP): a possible mechanism for transcriptional activation.Preprint
Chen, X., Farmer, G., Zhu, H., Prywes, R., & Prives, C. L. (1993) · Genes & Development · doi:10.1101/gad.7.10.1837 · Cited by 124
p53 downstream targets and chemosensitivity
Sax, J. K., & El‐Deiry, W. S. (2003) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401227 · Cited by 122
Self-citation
Tyrosinase Gene Expression is Regulated by p53
Khlgatian, M. K., Hadshiew, I., Asawanonda, P., Yaar, M., Eller, M. S., Gilchrest, B. A., Fujita, M., & Norris, D. A. (2002) · Journal of Investigative Dermatology · doi:10.1046/j.0022-202x.2001.01667.x · Cited by 121
Analysis of proliferation markers and p53 expression in gliomas of astrocytic origin: relationships and prognostic value
Cunningham, J. M., Kimmel, D. W., Scheithauer, B. W., O'Fallon, J. R., & Novotny, P. J. (1997) · Journal of neurosurgery · doi:10.3171/jns.1997.86.1.0121 · Cited by 122
Differential sensitivity of p53(-) and p53(+) cells to caffeine-induced radiosensitization and override of G2 delay.
Powell, S. N., DeFrank, J. S., Connell, P., Eogan, M., Preffer, F. I., Dombkowski, D., Tang, W., & Friend, S. H. (1995) · PubMed · Cited by 121
The Y-box-binding Protein, YB1, Is a Potential Negative Regulator of the p53 Tumor Suppressor
Lasham, A., Moloney, S., Hale, T. K., Homer, C. R., Zhang, Y. F., Murison, J. G., Braithwaite, A. W., & Watson, J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303920200 · Cited by 120
p53 and RPA Are Sequestered in Viral Replication Centers in the Nuclei of Cells Infected with Human Cytomegalovirus
Fortunato, E. A., & Spector, D. H. (1998) · Journal of Virology · doi:10.1128/jvi.72.3.2033-2039.1998 · Cited by 120
Preferential Inhibition of Akt and Killing of Akt-Dependent Cancer Cells by Rationally Designed Phosphatidylinositol Ether Lipid Analogues
Castillo, S. S., Brognard, J., Petukhov, P. A., Zhang, C., Tsurutani, J., Granville, C. A., Li, M., Jung, M., West, K. A., Gills, J. G., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-1530 · Cited by 121
Conformation-dependent phosphorylation of p53
Adler, V., Pincus, M. R., Minamoto, T., Fuchs, S. Y., Bluth, M. J., Brandt‐Rauf, P. W., Friedman, F. K., Robinson, R. C., Chen, J., Wang, X. W., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.5.1686 · Cited by 120
Wild-Type Human p53 Transactivates the Human Proliferating Cell Nuclear Antigen Promoter
Shivakumar, C. V., Brown, D. R., Deb, S., & Deb, S. P. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.12.6785 · Cited by 120
ATM’s Role in the Repair of DNA Double-Strand Breaks
Shibata, A., & Jeggo, P. A. (2021) · Genes · doi:10.3390/genes12091370 · Cited by 135
NOBEL LECTURE: Yeast and Cancer
Hartwell, L. H. (2002) · Bioscience Reports · doi:10.1023/a:1020918107706 · Cited by 116
Activation of p53 transcriptional activity requires ATM's kinase domain and multiple N-terminal serine residues of p53
Turenne, G. A., Paul, P., Laflair, L., & Price, B. D. (2001) · Oncogene · doi:10.1038/sj.onc.1204665 · Cited by 120
DNA damage‐induced apoptosis requires the DNA‐dependent protein kinase, and is mediated by the latent population of p53
Woo, R. A., Jack, M. T., Xu, Y., Burma, S., Chen, D. J., & Lee, P. W. K. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf307 · Cited by 122
Low-Dose Hypersensitivity and Increased Radioresistance in a Panel of Human Tumor Cell Lines with Different Radiosensitivity
Wouters, B. G., Sy, A. M., & Skarsgard, L. D. (1996) · Radiation Research · doi:10.2307/3579302 · Cited by 120
Ionizing Radiation-induced Cell Death
Szumiel, I. (1994) · International Journal of Radiation Biology · doi:10.1080/09553009414551271 · Cited by 120
What Does Cell Death Have To Do with Aging?
Warner, H. R., Hodes, R. J., & Pocinki, K. M. (1997) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1997.tb05981.x · Cited by 120
Increased apoptosis induction by 121F mutant p53
Saller, E., Tom, E., Brunori, M., Otter, M., Estreicher, A., Mack, D. H., & Iggo, R. D. (1999) · The EMBO Journal · doi:10.1093/emboj/18.16.4424 · Cited by 124

Authors: Kastan, M. B., Zhan, Q., El-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., & Fornace, A. J.
Affiliations: Johns Hopkins University (US)
National Cancer Institute (US)
Massachusetts Institute of Technology (US)
ORCID: Kastan, Michael B.
Zhan, Qimin
Carrier, France
Jacks, Tyler
Vogelstein, Bert
Fornace, Albert J.
Venue: Cell
Publisher: Elsevier BV
Published: 1992-11
Volume: 71
Issue: 4
Pages: 587-597
ISSN: 0092-8674 (ISSN-L)
DOI: 10.1016/0092-8674(92)90593-2
OpenAlex: W1986179131
Cited by: 3,047
References: 64
Citations by year: 2026: 11 · 2025: 16 · 2024: 17 · 2023: 20 · 2022: 23 · 2021: 23 · 2020: 24 · 2019: 16 · 2018: 31 · 2017: 34 · 2016: 35 · 2015: 43 · 2014: 44 · 2013: 30 · 2012: 48
FWCI: 86.58
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Cell (publishedVersion)
PubMed (publishedVersion)
Funders: National Cancer Institute (CA 09071, CA43460, T32CA009071)
National Institute of Environmental Health Sciences (ES05777)
Topics: Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Effects of Radiation Exposure
Keywords: ataxia telangiectasia, p53, GADD45, cell cycle checkpoints, G1/S checkpoint, ionizing radiation, DNA damage response, cell cycle arrest, signal transduction, cancer susceptibility, radiosensitivity
MeSH terms: Amino Acid Sequence, Animals, Ataxia Telangiectasia, Base Sequence, Cell Cycle, Cell Line, Cloning, Molecular, DNA Damage, DNA Repair, Gene Expression Regulation, Humans, Molecular Sequence Data, Genes, p53, Mutagenesis, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks